Survival signalling in keratinocytes of erythematous oral lichen planus

Journal of Oral Pathology and Medicine

Volumn 36, Issue 4, 2007, Pages 215-222

  Karatsaidis, Andreas ^a,b   Hayashi, Katsuhiko ^a,c   Schreurs, Olav ^a   Helgeland, Kristen ^a   Schenck, Karl ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; Keratinocytes; Oral lichen planus; Survival

Indexed keywords

CASPASE 3; CASPASE 8; FLICE INHIBITORY PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN 1; INHIBITOR OF APOPTOSIS PROTEIN 2; PROTEIN P50;

ARTICLE; CELL ACTIVATION; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; ERYTHEMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; KERATINOCYTE; LICHEN PLANUS; MOUTH MUCOSA; NORMAL HUMAN; ORAL BIOPSY; PRIORITY JOURNAL; STAINING; UPREGULATION;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CASE-CONTROL STUDIES; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CASPASE 3; CASPASE 8; CELL SURVIVAL; DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEINS; DNA-BINDING PROTEINS; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; FEMALE; HUMANS; I-KAPPA B KINASE; IMMUNOENZYME TECHNIQUES; INHIBITOR OF APOPTOSIS PROTEINS; KERATINOCYTES; LICHEN PLANUS, ORAL; MALE; NF-KAPPA B; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION;

EID: 33947662938     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2007.00519.x     Document Type: Article

References (37)

1. Thorn JJ, Holmstrup P, Rindum J, Pindborg JJ. Course of various clinical forms of oral lichen planus. A prospective follow-up study of 611 patients. J Oral Pathol 1988; 17: 213-8.
2. Silverman S Jr, Gorsky M, Lozada-Nur F, Giannotti K. A prospective study of findings and management in 214 patients with oral lichen planus. Oral Surg Oral Med Oral Pathol 1991; 72: 665-70.
3. Hedberg N, Ng A, Hunter N. A semi-quantitative assessment of the histopathology of oral lichen planus. J Oral Pathol 1986; 15: 268-72.
4. Schiodt M. Oral discoid lupus erythematosus: III. A histopathologic study of sixty-six patients. Oral Surg Oral Med Oral Pathol 1984; 57: 281-93.
5. Kim SG, Chae CH, Cho BO, et al. Apoptosis of oral epithelial cells in oral lichen planus caused by upregulation of BMP-4. J Oral Pathol Med 2006; 35: 37-45.
6. Santoro A, Majorana A, Bardellini E, et al. Cytotoxic molecule expression and epithelial cell apoptosis in oral and cutaneous lichen planus. Am J Clin Pathol 2004; 121: 758-64.
7. Tobon-Arroyave SI, Villegas-Acosta FA, Ruiz-Restrepo SM, Vieco-Duran B, Restrepo-Misas M, Londono-Lopez ML. Expression of caspase-3 and structural changes associated with apoptotic cell death of keratinocytes in oral lichen planus. Oral Dis 2004; 10: 173-8.
8. Khan A, Farah CS, Savage NW, Walsh LJ, Harbrow DJ, Sugerman PB. Th1 cytokines in oral lichen planus. J Oral Pathol Med 2003; 32: 77-83.
9. Yamamoto T, Osaki T. Characteristic cytokines generated by keratinocytes and mononuclear infiltrates in oral lichen planus. J Invest Dermatol 1995; 104: 784-8.
10. Neppelberg E, Johannessen AC, Jonsson R. Apoptosis in oral lichen planus. Eur J Oral Sci 2001; 109: 361-4.
11. Sklavounou A, Chrysomali E, Scorilas A, Karameris A. TNF-alpha expression and apoptosis-regulating proteins in oral lichen planus: a comparative immunohistochemical evaluation. J Oral Pathol Med 2000; 29: 370-5.
12. Micheau O, Lens S, Gaide O, Alevizopoulos K, Tschopp J. NF-kappaB signals induce the expression of c-FLIP. Mol Cell Biol 2001; 21: 5299-305.
13. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS Jr. NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 1998; 281: 1680-3.
14. Lippens S, Denecker G, Ovaere P, Vandenabeele P, Declercq W. Death penalty for keratinocytes: apoptosis vs. cornification. Cell Death Differ 2005; 12 (Suppl. 2): 1497-508.
15. Karatsaidis A, Schreurs O, Helgeland K, Axell T, Schenck K. Erythematous and reticular forms of oral lichen planus and oral lichenoid reactions differ in pathological features related to disease activity. J Oral Pathol Med 2003; 32: 275-81.
16. Karatsaidis A, Schreurs O, Axell T, Helgeland K, Schenck K. Identity of TUNEL-positive cells in the oral buccal epithelium of normal mucosa and lichen lesions. J Oral Pathol Med 2004; 33: 264-8.
17. Muppidi JR, Tschopp J, Siegel RM. Life and death decisions: secondary complexes and lipid rafts in TNF receptor family signal transduction. Immunity 2004; 21: 461-5.
18. Micheau O, Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 2003; 114: 181-90.
19. Poyet JL, Srinivasula SM, Alnemri ES. vCLAP, a caspaserecruitment domain-containing protein of equine Herpesvirus-2, persistently activates the Ikappa B kinases through oligomerization of IKKgamma. J Biol Chem 2001; 276: 3183-7.
20. Hsu H, Huang J, Shu HB, Baichwal V, Goeddel DV. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 1996; 4: 387-96.
21. Hsu H, Shu HB, Pan MG, Goeddel DV. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 1996; 84: 299-308.
22. Moynagh PN. The NF-kappaB pathway. J Cell Sci 2005; 118: 4589-92.
23. Krueger A, Schmitz I, Baumann S, Krammer PH, Kirchhoff S. Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex. J Biol Chem 2001; 276: 20633-40.
24. Irmler M, Thome M, Hahne M, et al. Inhibition of death receptor signals by cellular FLIP. Nature 1997; 388: 190-5.
25. Janes KA, Gaudet S, Albeck JG, Nielsen UB, Lauffenburger DA, Sorger PK. The response of human epithelial cells to TNF involves an inducible autocrine cascade. Cell 2006; 124: 1225-39.
26. Wehkamp K, Schwichtenberg L, Schroder JM, Harder J. Pseudomonas aeruginosa- and IL-1beta-mediated induction of human beta-defensin-2 in keratinocytes is controlled by NF-kappaB and AP-1. J Invest Dermatol 2006; 126: 121-7.
27. Rhodus NL, Cheng B, Myers S, Bowles W, Ho V, Ondrey F. A comparison of the pro-inflammatory, NF-kappaBdependent cytokines: TNF-alpha, IL-1-alpha, IL-6, and IL-8 in different oral fluids from oral lichen planus patients. Clin Immunol 2005; 114: 278-83.
28. Wang Y, Kim PK, Peng X, et al. Cyclic AMP and Cyclic GMP suppress TNFalpha-induced hepatocyte apoptosis by inhibiting FADD up-regulation via a protein kinase Adependent pathway. Apoptosis 2006; 11: 441-51.
29. Kim PK, Wang Y, Gambotto A, et al. Hepatocyte Fasassociating death domain protein/mediator of receptorinduced toxicity (FADD/MORT1) levels increase in response to pro-apoptotic stimuli. J Biol Chem 2002; 277: 38855-62.
30. Screaton RA, Kiessling S, Sansom OJ, et al. Fas-associated death domain protein interacts with methyl-CpG binding domain protein 4: a potential link between genome surveillance and apoptosis. Proc Natl Acad Sci U S A 2003; 100: 5211-6.
31. Roy N, Deveraux QL, Takahashi R, Salvesen GS, Reed JC. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J 1997; 16: 6914-25.
32. Deveraux QL, Roy N, Stennicke HR, et al. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J 1998; 17: 2215-23.
33. Adrain C, Martin SJ. The mitochondrial apoptosome: a killer unleashed by the cytochrome seas. Trends Biochem Sci 2001; 26: 390-7.
34. Zou H, Li Y, Liu X, Wang X. An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J Biol Chem 1999; 274: 11549-56.
35. Luo X, Budihardjo I, Zou H, Slaughter C, Wang X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 1998; 94: 481-90.
36. Leist M, Jaattela M. Four deaths and a funeral: from caspases to alternative mechanisms. Nat Rev Mol Cell Biol 2001; 2: 589-98.
37. Hague A, Eveson JW, MacFarlane M, Huntley S, Janghra N, Thavaraj S. Caspase-3 expression is reduced, in the absence of cleavage, in terminally differentiated normal oral epithelium but is increased in oral squamous cell carcinomas and correlates with tumour stage. J Pathol 2004; 204: 175-82.